Systemic Lupus Erythematosus Within the Framework of the Multidisciplinary Consultation
Overview
Diagnosis and follow up of a lupus cohort in a multidisciplinary consultation in Brest ( France)
Full Title of Study: “Cohort Follow-up of Systemic Lupus Erythematosus Within the Framework of the Multidisciplinary Consultation at the CHRU of Brest”
Study Type
- Study Type: Interventional
- Study Design
- Allocation: N/A
- Intervention Model: Single Group Assignment
- Primary Purpose: Diagnostic
- Masking: None (Open Label)
- Study Primary Completion Date: May 13, 2025
Detailed Description
all patients coming to the LUPUS multidisciplinary consultation in brest ( France) will have a clinical examination, a biological and immunogical blood samples, cutaneous biopsies or renal biospies if necessary, an ultrasonographic articular and salivary glandular examination if needed. In case of articular involvement, some Xrays ( hands and feet) will be done at the inclusion and during the follow up each year during 5 years .
Interventions
- Other: description of a lupus patient cohort
- description of a lupus patient cohort
Arms, Groups and Cohorts
- Other: lupus cohort follow up
- it is a descrption lupus patients study
Clinical Trial Outcome Measures
Primary Measures
- Cohort lupus: epidemiologic lupus study about diagnosis and follow up
- Time Frame: five years
- epidemiologic lupus study in collecting data ( description of the population, biologic and immunologic data collection, data of articular damges with xrays datas) about Diagnosis and follow up of a cohort lupus in a multidisciplibnary consultation in brest hospital ( France).
Participating in This Clinical Trial
Inclusion Criteria
- women or men, more than 18 years old, coming to the multidisciplinary consultation in brest ( France). – With written consentment Exclusion Criteria:
- patients less than 18 years old – refusing to participate – Under legal protection
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: 80 Years
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- University Hospital, Brest
- Provider of Information About this Clinical Study
- Sponsor
- Overall Contact(s)
- sandrine jousse joulin, MD, +33 2 98 34 72 68, sandrine.jousse-oulin@chu-brest.fr
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.